Lexaria Bioscience Corp. LEXX
Set alert
4.00 USD +0.36 +9.89%
As of Nov 3, 2:44 PM ET
3.79 Day range 4.10
2.43 52-week range 21.60
- YTD
- -56.80%
- 1 year
- -74.36%
- Open
- 3.79
- Prev close
- 3.64
- Mkt cap
- 8.43M
- Vol
- 19.51K
- Avg vol
- 74.60K
- EPS
- -5.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.79
- High
- 4.10
- Forward P/E
- -5.64
- Beta
- 1.06
- Short ratio
- 2.34
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 10, 2025
- 50-d avg
- 2.38
- 200-d avg
- 2.99
- 1y target
- 10.00
Analyst view
Consensus: buy
Buy
Price target (mean) 10.00 +150.0% upside
Now 4.00
- Target (low)
- 8.00
- Target (mean)
- 10.00
- Target (high)
- 12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00K | -33.9% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00K | -31.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 548.00K | +18.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 584.50K | +6.7% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 10, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 5, 2024 | Maxim Group | Maintained | Buy | Buy |
| Jul 21, 2023 | Maxim Group | Initiated | — | Buy |